He Shuai, Lei Zheng-jie, Zhang Shou-yao, Zhang Zhong-yi
Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Yao Xue Xue Bao. 2009 May;44(5):532-9.
The purpose of this study is to explore the feasibility and superiority of using rapid expansion of supercritical solution (RESS) technology in the field of traditional Chinese medicine. The extract of magnolia bark (EMB) was obtained by supercritical carbon dioxide (SCF-CO2) extraction technology. Microparticles of EMB were manufactured by RESS technology. The effects of operating temperature and pressure on the contents of the active ingredient in the particles were evaluated by HPLC. The effect of expansion conditions on the particle size distribution of EMB particles was investigated. The smallest sample (mean size: 4.7 microm) was obtained under the RESS condition: pressure of 25 MPa, temperature of 50 degrees C and a nozzle size of 100 microm. The characteristics of microparticles were also studied by differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and image analysis. The dissolution rate study showed that microparticles had a significantly faster dissolution rate than normal material particles. After oral raw EMB suspension, the mean areas under the plasma concentration-time curves (AUC(0-t)) of honokiol and magnolol were found to be (4.23 +/- 0.36) and (5.46 +/- 0.57) mg x h x L(-1), respectively, which were increased significantly, i.e. (5.41 +/- 0.63) and (7.24 +/- 0.83) mg x h x L(-1) when micronized EMB suspension was administered orally in SD rats (P < 0.05). Similarly, the mean maximum plasma concentrations of honokiol and magnolol increased from (1.55 +/- 0.22) and (2.35 +/- 0.14) mg x L(-1) (raw EMB) to (2.31 +/- 0.17) and (2.84 +/- 0.21) mg x L(-1) (micronized EMB), respectively. The results of t-test demonstrated that AUC(0-t) and Cmax value for honokiol and magnolol was significantly increased with the micronization compared to raw EBM (P < 0.05). This study demonstrated that the RESS was applicable for preparing microparticles of EMB at low operating temperature. The process was simple, free of environment pollution and without residual solvent.
本研究旨在探讨超临界溶液快速膨胀(RESS)技术在中药领域应用的可行性和优越性。厚朴树皮提取物(EMB)采用超临界二氧化碳(SCF-CO₂)萃取技术获得。通过RESS技术制备EMB微粒。采用高效液相色谱法(HPLC)评估操作温度和压力对微粒中活性成分含量的影响。研究了膨胀条件对EMB微粒粒径分布的影响。在RESS条件下:压力25MPa、温度50℃、喷嘴尺寸100μm时,获得了最小的样品(平均粒径:4.7微米)。还通过差示扫描量热法(DSC)、扫描电子显微镜(SEM)和图像分析对微粒特性进行了研究。溶出速率研究表明,微粒的溶出速率明显快于普通物料颗粒。给SD大鼠口服厚朴树皮生药混悬液后,厚朴酚和和厚朴酚的血浆浓度-时间曲线下平均面积(AUC(0-t))分别为(4.23±0.36)和(5.46±0.57)mg·h·L⁻¹,显著升高,即口服微粉化EMB混悬液时分别为(5.41±0.63)和(7.24±0.83)mg·h·L⁻¹(P<0.05)。同样,厚朴酚和和厚朴酚的平均最大血浆浓度分别从(1.55±0.22)和(2.35±0.14)mg·L⁻¹(厚朴树皮生药)增至(2.31±0.17)和(2.84±0.21)mg·L⁻¹(微粉化EMB)。t检验结果表明,与厚朴树皮生药相比,厚朴酚和和厚朴酚的AUC(0-t)和Cmax值因微粉化而显著升高(P<0.05)。本研究表明,RESS适用于在低温操作条件下制备EMB微粒。该工艺简单,无污染且无残留溶剂。